ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Ufmylation-Deficient DDRGK1 Ameliorates Obesity by Inhibiting FASN-Mediated Adipocyte Lipogenesis.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Contrasting Starvation Strategies in Congeneric Pentatomids: A Predator (Arma chinensis) Versus a Pest (Halyomorpha halys).Archives of insect biochemistry and physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Fatty acid synthase (FASN) is a central regulator of obesity through de novo lipogenesis (DNL), undergoes precise control via the ubiquitin-proteasome system, yet its obesity-related post-translational modifications remain unclear. Our clinical investigation of human adipose tissue (n = 23) demonstrated elevated FASN protein in overweight individuals, mirroring high-fat diet (HFD) mouse models. However, transcriptomic analysis of 770 GEO samples paradoxically revealed inverse correlation between FASN mRNA and BMI. Mechanistically, we identified DDRGK1 as a UFMylation effector that stabilizes FASN by competitively inhibiting ubiquitination. Genetic disruption of this pathway in Ddrgk1
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.